Patient information

UKC Tuzla updates the list of medicines not supplied by the Solidarity Fund

The official list dated 6 November includes four medicines; patients should confirm the latest availability with their clinical team before attending or receiving treatment.

University Clinical Centre Tuzla building
Image from the official institutional announcement: UKC Tuzla — Lista nedostajućih lijekova Fonda zdravstvenog osiguranja FBiH

University Clinical Centre Tuzla published an updated notice on 6 November 2026 about medicines that the Federation of Bosnia and Herzegovina Health Insurance and Reinsurance Fund had not supplied to the institution by that date. The list names idarubicin, mitoxantrone, pemetrexed 500 mg and everolimus 10 mg.

The notice is a snapshot for the stated date and availability may change. Patients should not stop, postpone or alter treatment on their own. Before a scheduled visit, they should contact the responsible clinic or treating doctor to confirm the current position and any effect on their treatment plan.

Zdravo BiH does not provide individual medical advice. Use the official UKC Tuzla notice or contact the institution directly for the latest list and instructions.

Official sourceUKC Tuzla — Lista nedostajućih lijekova Fonda zdravstvenog osiguranja FBiHSource checked: 08/11/2026
Open original announcement
The image was downloaded from the linked official institutional announcement and is displayed with source attribution. Rights remain with the original publisher.
Browse all news